Endostatin's antiangiogenic signaling network

被引:361
作者
Abdollahi, A
Hahnfeldt, P
Maercker, C
Gröne, HJ
Debus, J
Ansorge, W
Folkman, J
Hlatky, L
Huber, PE
机构
[1] Univ Heidelberg, Sch Med, Dept Radiat Oncol, German Canc Res Ctr, Heidelberg, Germany
[2] Univ Heidelberg, Sch Med, Dept Radiat Oncol, Heidelberg, Germany
[3] Harvard Univ, Sch Med, Dept Radiat Oncol, Dana Farber Canc Inst, Boston, MA USA
[4] German Genome Resource Ctr, Berlin, Germany
[5] German Canc Res Ctr, Dept Mol Pathol, D-6900 Heidelberg, Germany
[6] European Mol Biol Lab, Heidelberg, Germany
[7] Harvard Univ, Sch Med, Surg Res Lab, Dept Surg,Childrens Hosp, Boston, MA 02115 USA
[8] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA
[9] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA
关键词
D O I
10.1016/S1097-2765(04)00102-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It is here demonstrated that the set of gene expressions underlying the angiogenic balance in tissues can be molecularly reset en masse by a single protein. Using genome-wide expression profiling, coupled with RT-PCR and phosphorylation analysis, we show that the endogenous angiogenesis inhibitor endostatin down-regulates many signaling pathways in human microvascular endothelium associated with proangiogenic activity. Simultaneously, endostatin is found to upregulate many antiangiogenic genes. The result is a unique alignment between the direction of gene regulation and angiogenic status. Profiling further reveals the regulation of genes not heretofore associated with angiogenesis. Our analysis of coregulated genes shows complex interpathway communications in an intricate signaling network that both recapitulates and extends on current understanding of the angiogenic process. More generally, insights into the nature of genetic networking from the cell biologic and therapeutic perspectives are revealed.
引用
收藏
页码:649 / 663
页数:15
相关论文
共 80 条
  • [61] HIF-1 and tumor progression: pathophysiology and therapeutics
    Semenza, GL
    [J]. TRENDS IN MOLECULAR MEDICINE, 2002, 8 (04) : S62 - S67
  • [62] The ETS-domain transcription factor family
    Sharrocks, AD
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2001, 2 (11) : 827 - 837
  • [63] AP-1 as a regulator of cell life and death
    Shaulian, E
    Karin, M
    [J]. NATURE CELL BIOLOGY, 2002, 4 (05) : E131 - E136
  • [64] Antiangiogenesis signals by endostatin
    Shichiri, M
    Hirata, Y
    [J]. FASEB JOURNAL, 2001, 15 (06) : 1044 - 1053
  • [65] c-Jun N-terminal kinase is involved in motility of endothelial cell
    Shin, EY
    Kim, SY
    Kim, EG
    [J]. EXPERIMENTAL AND MOLECULAR MEDICINE, 2001, 33 (04) : 276 - 283
  • [66] Expression of transcription factor AP-1 in rat lens epithelial cells during wound repair
    Shirai, K
    Okada, Y
    Saika, S
    Senba, E
    Ohnishi, Y
    [J]. EXPERIMENTAL EYE RESEARCH, 2001, 73 (04) : 461 - 468
  • [67] Shono T, 1996, MOL CELL BIOL, V16, P4231
  • [68] Siegbahn A, 2000, HAEMOSTASIS, V30, P41
  • [69] Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer
    Sovak, MA
    Bellas, RE
    Kim, DW
    Zanieski, GJ
    Rogers, AE
    Traish, AM
    Sonenshein, GE
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (12) : 2952 - 2960
  • [70] Human tumstatin land human endostatin exhibit distinct antiangiogenic activities mediated by αvβ3 and α5β1 integrins
    Sudhakar, A
    Sugimoto, H
    Yang, CQ
    Lively, J
    Zeisberg, M
    Kalluri, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (08) : 4766 - 4771